Strategic Shifts in Global Pharma: Analyzing Recent Market Movements
Global pharmaceutical markets are experiencing a period of intense recalibration this week as Merck, Kelun-Biotech, and Recordati announce major strategic pivots that are reshaping investor expectations. These developments, emerging from recent industry disclosures, highlight a broader trend of targeted acquisitions and high-stakes clinical partnerships designed to solidify market share in oncology and rare disease sectors….